about
Hospital-acquired Aspergillus fumigatus infection: can molecular typing methods identify an environmental source?Cryptococcus neoformans typing by PCR fingerprinting using (GACA)4 primers based on C. neoformans genome project data.Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattiiKnowledge about tuberculosis among undergraduate health care students in 15 Italian universities: a cross-sectional studyMulticenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of MucoralesPharmacokinetics of ketoconazole and treatment evaluation in candidal infections.Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant population.Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases.Primary Cutaneous Coccidioidomycosis in an Italian Nun Working in South America and Review of Published Literature.Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature.Molecular epidemiology of Italian clinical Cryptococcus neoformans var. grubii isolates.Reviewing the importance and evolution of fungal infections and potential antifungal resistance in haematological patients.CAND-LO 2014-15 study: changing epidemiology of candidemia in Lombardy (Italy).Two new cases of cutaneous alternariosis with a review of the literature.Antibiotic resistance: Italian awareness survey 2016.Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.Fusarium musae as cause of superficial and deep-seated human infections.Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture CollectionInvasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008).Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008).Candidosis in the intensive care unit: a 20-year survey.Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood.Comparison of effects of human serum and horse serum on in vitro susceptibility testing of echinocandins.Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.In vitro activity of conventional antifungal drugs and natural essences against the yeast-like alga Prototheca.Antifungal susceptibility profiles of Candida isolates from a prospective survey of invasive fungal infections in Italian intensive care units.In vitro testing of fungicidal activity of biocides against Aspergillus fumigatus.Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.Candida colonization in patients with esophageal disease: a prospective clinical study.Posaconazole MIC distributions for Aspergillus fumigatus SC by four methods: Impact of Cyp51A mutations on estimation of epidemiological cutoff values (ECVs/ECOFFs).
P50
Q30860934-A22B99FD-E6D8-4E73-AB6F-9688DAAF96E6Q31120555-EAF0D6D7-D8C5-4F17-8C0B-DE2C7C9ECDF7Q34007574-ED777CF4-E58F-4422-98C9-3F78CE566159Q34264267-F4ED0CA1-7C39-4C8E-B4C2-9AABB18D1A88Q34316698-5ADD1C50-EB55-4B5E-9A77-E7C753DB97CBQ35076896-87DA334F-602E-49B0-9C71-42CDF38EAE5FQ35118504-62BF7D84-A3B8-42AE-B70C-222387A9E1C3Q36020365-50E2FC0F-D1FA-43D7-9E63-F464427810DCQ36571990-C2B72ED7-D689-47B6-A53A-89FADC8891C5Q36583160-19C9FEF6-F548-4C0F-B2AB-ABF426F77C80Q38062286-E86C918C-0240-4EA6-A7F6-61F59DADBCD3Q38455267-09FB70F1-7DE4-4C31-AD31-F5FC37550AD1Q38786385-02BF7C41-0974-4ADF-AFF4-091163A62E76Q38866327-9253E270-26CD-4016-B6D4-079C162BE490Q39008488-25728D06-0D6D-4551-911C-6D8389259A4EQ39278962-65BC969F-913D-4A01-BC67-4052E588D98CQ39752556-B62A5E37-0CB6-4983-96B5-70194A269116Q40065621-41D14213-012C-40A7-BA53-4890E02ABEA7Q40524039-92DD0271-83C7-401A-B0DF-C5A6AF82BDD1Q40709019-7766B8B3-2CAD-4E57-86A0-5CC22AC16ACBQ41137048-6DF0A5BA-BAA1-432A-91BA-36978DC4B466Q41503949-946591B6-0090-4895-B7EA-9E33F9131AFBQ41542809-C7C364EC-0349-4B46-A4AD-56D6E7B5A85CQ42227953-EE5C630E-8793-48BC-AAAF-B5DED862B827Q42230330-BD3D3739-D2E7-45D7-BD63-57C789DEBE7CQ42230463-67B84841-C43E-443E-9447-EBBC32D94864Q43976981-3A7AFFE2-FF11-47B9-A673-2FB1E5AA0876Q44020369-F4112201-63F1-4578-ABF2-BA580292B3AAQ44062752-5125033E-733C-4AE3-98C1-7D5230E0B850Q44204150-51FC0340-6AF8-4832-9C60-F20B1A363695Q44570705-FBDD066D-C531-4021-99F3-DA0859DAEE14Q44721081-C0710C41-7A46-4C80-A1AD-083380D63BF3Q44733084-643A3C54-6C94-49E5-82FE-E7FE76B3C27DQ44918229-C80D60D7-D755-476C-9CD5-244113B44592Q44935299-84B4DBF4-F89D-4BA8-AF50-C9108F67EF2CQ46699034-7109E676-73FF-4B9C-BAD9-0D6F8D6F3017Q46818343-50256016-F72C-4957-942E-E3D7B9C65C1AQ46898666-805FBD6B-F72F-4EAD-9396-3015AFC851A4Q47809033-B574C295-A8B5-48D5-8825-3564793523B3Q50044341-BD0169E5-909A-4542-8FC4-921A0E7E6EC8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Maria Tortorano
@ast
Anna Maria Tortorano
@en
Anna Maria Tortorano
@es
Anna Maria Tortorano
@nl
type
label
Anna Maria Tortorano
@ast
Anna Maria Tortorano
@en
Anna Maria Tortorano
@es
Anna Maria Tortorano
@nl
prefLabel
Anna Maria Tortorano
@ast
Anna Maria Tortorano
@en
Anna Maria Tortorano
@es
Anna Maria Tortorano
@nl
P106
P1153
7003670629
P21
P31
P496
0000-0003-2093-8250